Connecting clinicians, academics and industry to accelerate prostate cancer breakthroughs

Through PCR’s translational programme, Proven Connect, an increasing number of companies are seeking to connect to academics in specialist areas of...

Thanks to Proven Connects investor partnership with UKRI we were able to be the lead the latest investment round Nanovery

Thanks to Proven Connects investor partnership with UKRI we were able to be the lead the latest investment round Nanovery. Nanovery have successful...

Download our report recent PCR Report “Unlocking the Potential of Prostate Cancer Data” that highlights the challenges that researchers have in accessing health-related data.

Our report PCR Report “Unlocking the Potential of Prostate Cancer Data” highlights the challenges that researchers have in accessing health-related...

Congratulations to the finalists

Proven Connect was delighted to partner with Lean Life Science for a new Oncology programme launching in 2023. Applications for the programme are n...

PCR has been granted investor partner status for the UK governments new aligned funding scheme

Description Innovate UK, as part of UK Research and Innovation, has selected a pool of investor partners. These investor partners have demonstra...

Prostate Cancer Research has announced a new programme of work that will deliver on the charity’s commitment to support and accelerate translational research. Proven Connect will work to improve access to seed funding, expertise and networks and to build collaborations and partnerships in the translational research space.

Through Proven Connect, PCR will co-invest with venture capital funders and impact investors and connect companies to the resources and expert supp...